Joao A R Assad
Overview
Explore the profile of Joao A R Assad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
792
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vela D, Silva G, Assad J, Sousa A, Coulter S, Fernandes M, et al.
J Histochem Cytochem
. 2008 Nov;
57(2):167-76.
PMID: 19001635
In this histological study, we assessed the role of mesenchymal stem cells (MSCs) in the healing process that takes place during the subacute phase of myocardial infarction in dogs. Seven...
2.
Perin E, Silva G, Assad J, Vela D, Buja L, Sousa A, et al.
J Mol Cell Cardiol
. 2007 Dec;
44(3):486-95.
PMID: 18061611
This study assessed safety of transendocardial (TE) electromechanical-guided delivery of bone marrow mesenchymal stem cells (MSCs) after acute myocardial infarction (AMI) and compared intracoronary (IC) delivery with TE delivery. In...
3.
Dohmann H, Perin E, Takiya C, Silva G, Silva S, Sousa A, et al.
Circulation
. 2005 Jul;
112(4):521-6.
PMID: 16027258
Background: Cell-based therapies for treatment of ischemic heart disease are currently under investigation. We previously reported the results of a phase I trial of transendocardial injection of autologous bone marrow...
4.
Dohmann H, Perin E, Borojevic R, Silva S, Souza A, Silva G, et al.
Arq Bras Cardiol
. 2005 May;
84(5):360-6.
PMID: 15917966
Objective: This study aimed at assessing the effects of autologous transendocardial transplantation of bone marrow mononuclear cells (ATTBMMC) on symptoms, exercise capacity, myocardial perfusion and contractility in patients with severe...
5.
Silva G, Litovsky S, Assad J, Sousa A, Martin B, Vela D, et al.
Circulation
. 2005 Jan;
111(2):150-6.
PMID: 15642764
Background: Bone marrow-derived stem cells are under investigation as a treatment for ischemic heart disease. Mesenchymal stem cells (MSCs) have been used preferentially in the acute ischemia model; data in...
6.
Silva G, Perin E, Dohmann H, Borojevic R, Silva S, Sousa A, et al.
Tex Heart Inst J
. 2004 Nov;
31(3):214-9.
PMID: 15562839
Growing evidence suggests that transplantation of autologous bone-marrow mononuclear cells (ABMMNCs) can improve the perfusion and contractile function of ischemic myocardium. This procedure could potentially benefit transplant candidates awaiting a...
7.
Perin E, Dohmann H, Borojevic R, Silva S, Sousa A, Silva G, et al.
Circulation
. 2004 Sep;
110(11 Suppl 1):II213-8.
PMID: 15364865
Background: We recently reported the safety and feasibility of autologous bone marrow mononuclear cell (ABMMNC) injection into areas of ischemic myocardium in patients with end-stage ischemic cardiomyopathy. The present study...
8.
Perin E, Dohmann H, Borojevic R, Silva S, Sousa A, Mesquita C, et al.
Circulation
. 2003 Apr;
107(18):2294-302.
PMID: 12707230
Background: This study evaluated the hypothesis that transendocardial injections of autologous mononuclear bone marrow cells in patients with end-stage ischemic heart disease could safely promote neovascularization and improve perfusion and...